LCB14-2524
/ LG Chem
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 20, 2026
LigaChem Bio announced on March 18 that it will present research findings on its BCMA ADC pipelines, 'LCB14-2524' and 'LCB14-2516' (development codes), in poster format at the American Association for Cancer Research (AACR 2026), scheduled to take place in San Diego, USA, from April 17 to 22 (local time).
(The Bio)
- "LigaChem Bio reported that both candidates demonstrated superior cytotoxicity and efficacy compared to the control group, Blenrep, in preclinical evaluations."
Preclinical • Multiple Myeloma
1 to 1
Of
1
Go to page
1